Calidi Biotherapeutics
CLDI
CLDI
20 hedge funds and large institutions have $363K invested in Calidi Biotherapeutics in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
61% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 18
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$119K | |
| 2 | +$57.4K | |
| 3 | +$34.1K | |
| 4 |
AMH
Apollo Management Holdings
New York
|
+$18.1K |
| 5 |
EWM
Evermay Wealth Management
Arlington,
Virginia
|
+$9.2K |
Top Sellers
| 1 | -$52.7K | |
| 2 | -$25.2K | |
| 3 | -$23.2K | |
| 4 |
HF
HRT Financial
New York
|
-$20K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$18.9K |